Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 92 pseudogene 1, Y-linked (ZNF92P1Y) is annotated as a pseudogene and not a functional gene product. The “zinc finger” protein family refers to a group of transcription factors containing zinc finger motifs involved in DNA binding and regulation of gene expression, but ZNF92P1Y itself lacks evidence of protein coding capacity or biological function[5][3]. Its designation as a pseudogene means it is generally considered nonfunctional, likely formed by duplication or retrotransposition events in evolution, and is not considered a therapeutic drug target or receptor. There is no information linking ZNF92P1Y to disease, therapeutic intervention, or biomarker development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 92 pseudogene 1, Y-linked (ZNF92P1Y).